Response to comments on Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil

被引：1
|
作者：
Auriacombe, S [1 ]
Pere, JJ [1 ]
机构：
[1] Clin St Augustin, Bordeaux, France
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2002年 / 18卷 / 06期
关键词：
D O I：
10.1185/030079902125000958
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：IV / VI
页数：3
相关论文
共 50 条
  • [21] An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment for treatment of Alzheimer's disease
    Shua-Haim, JR
    Pass, M
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 356 - 356
  • [22] An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease
    Shua-Haim, JR
    Pass, MD
    Patel, S
    Lee, P
    Patel, P
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S196 - S196
  • [23] Efficacy and safety of rivastigmine in patients with Alzheimer's disease:: international randomised controlled trial
    Rösler, M
    Anand, R
    Cicin-Sain, A
    Gauthier, S
    Agid, Y
    Dal-Bianco, P
    Stähelin, HB
    Hartman, R
    Gharabawi, M
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1999, 318 (7184): : 633 - 638
  • [24] Efficacy and safety of Rivastigmine (Exelon) in Alzheimer's disease patients with vascular risk factors
    Kumar, V
    Sugaya, K
    Messina, J
    Veach, J
    [J]. NEUROLOGY, 1999, 52 (06) : A395 - A396
  • [25] Switching from Donepezil Tablets to Rivastigmine Transdermal Patch in Alzheimer's Disease
    Sadowsky, Carl H.
    Dengiz, Alan
    Olin, Jason T.
    Koumaras, Barbara
    Meng, Xiangyi
    Brannan, Stephen
    [J]. AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2009, 24 (03): : 267 - 275
  • [26] The safety and tolerability of donepezil in patients with Alzheimer's disease
    Jackson, S
    Ham, RJ
    Wilkinson, D
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 : 1 - 8
  • [27] Donepezil in the treatment of patients with Alzheimer's disease
    Tsuno, Norifumi
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (05) : 591 - 598
  • [28] Efficacy of donepezil in the treatment of patients with Alzheimer's disease with or without concomitant cerebrovascular disease
    Kamleiter, M
    Schmidtke, K
    [J]. STROKE, 2004, 35 (06) : E324 - E324
  • [29] The response of patients with Alzheimer's disease to rivastigmine treatment is predicted by the rate of disease progression
    Farlow, MR
    Hake, AM
    Messina, J
    Veach, J
    Anand, R
    [J]. NEUROLOGY, 2000, 54 (07) : A469 - A470
  • [30] SWAP: Safety and tolerability of switching oral donepezil to rivastigmine patch in Alzheimer's disease (AD)
    Alva, Gustavo
    Farlow, Martin
    Sadowsky, Carl
    Brannan, Stephen
    [J]. ANNALS OF NEUROLOGY, 2008, 64 : S39 - S40
12345